Chou, Wen-Chi
, M.D.
Institution: Chang Gung Memorial Hospital (CGMH) at Linkou
Position: Attending physician, Division of Hematology-Oncology, CGMH
Assistant Professor, CGMH
Department: Division of Hematology-Oncology, Department of Internal Medicine,
Address: No.5, Fusing St., Gueishan Township, Taoyuan County 333, Taiwan (R.O.C.)
Tel: +886-3-3281200 ext 8825
E-mail:
wenchi3992@yahoo.com.tw
Focus of Interest:- Oncology and palliative care
Fulltime Employment :Attending physician, Division of Hematology-Oncology, CGMH
Education:1993-2000 Medical Degree, Taipei MedicalCollege, Taipei, Taiwan
2011- present PhD student, Graduate Institute of Clinical Medical Science, Chang Gung University
Honor and Awards:Best Intern, June 1999 to June 2000, CGMH
Year Resident of Internal Medicine, 2000, 2001, 2002, 2003, CGMH
Year Teaching Resident, 2000, 2001, CGMH
Selected Publications:1. Chou WC, Lu CH, Lin G, Hung YS, Chen PT, Hsu CH, Chen JS, Yeh KY, Wang HM, Liaw CC*. Transcutaneous arterial embolization to control massive tumor bleeding in head and neck cancer: 63 patients' experiences from a single medical center. Support Care Cancer. 2007;15(10):1185-1190.
2. Chou WC, Hung YS, Hsu JT*, Chen JS, Lu CH, Hwan TL, Rau KM, Yeh KY, Chen TC, Sun CF. Chromogranin A is a reliable biomarker for gastroenteropancreatic neuroendocrine tumors in an Asian population of patients. Neuroendocrinology 2012; 95:344-350.
3. Chou WC, Hung YS, Kao CY, Su PJ, Hsieh CH, Chen JS, Liau CT, Lin YC, Liaw CC, Wang HM*. Impact of palliative care consultative service on disease awareness for patients with terminal cancer. Support Care Cancer. 2013 Jul;21(7):1973-81
4. Chou WC, Lai YT, Huang YC, Chang CL, Wu WS, Hung YS*. Comparing end-of-life care for hospitalized patients with chronic obstructive pulmonary disease and lung cancer in Taiwan. J Palliat Care. 2013;29(1):29-35.
Full Publication List
Board Certification/Professional Affiliations:
2003 Board of Internal Medicine R.O.C.
2005 Board of Medical Oncology R.O.C.
2008 Bord of Taiwan Society of Cancer Palliative Medicine
2009 Lecturer
Ongoing Projects:1. 2012/5 -2017/11 A randomized, double-blind, multicenter, Phase III study of everolimus (RAD001) plus best supportive care versus placebo plus best supportive care in the treatment of patients with advanced NET of GI or lung origin -RADIANT-4
2. 2012/9- 2017/5 The Clinical Significance of Extracellular Matrix/Integrin and TGF Signaling Pathway Biomarkers in Patients with Pancreatic Cancer
3. 2012/10- 2017/12 A randomized, multicenter, adaptive phase ii/iii study to evaluate the efficacy and safety of trastuzumab emtansine (t-dm1) versus taxane (docetaxel or paclitaxel) in patients with previously treated locally advanced or metastatic her-2-positive gastric cancer, including adenocarcinoma of the gastroesophageal junction